MedPath

Improving respiration with oxygen evaluatio

Recruiting
Conditions
ResuscitationPreterm infantsOxygen
Registration Number
NL-OMON28498
Lead Sponsor
eiden University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Preterm infants of 24-30 weeks of gestation will be randomized to start stabilisation after birth with a FiO2 of either 1.0 or 0.3, after which FiO2 will be titrated based on oxygen saturation.

Exclusion Criteria

Congenital abnormality or condition that might have an adverse effect on breathing or ventilation, if these conditions are not already diagnosed before birth, including: congenital diaphragmatic hernia, trachea-oesophageal fistula or cyanotic heart disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main study parameter is respiratory effort, expressed as:<br>-Average respiratory minute volume in the first 5 minutes after birth <br>
Secondary Outcome Measures
NameTimeMethod
Secondary study parameters are;<br /><br>-Interaction of respiratory minute volume in the first 5 minutes after birth with time<br /><br>-Average tidal volumes in the first 5 minutes after birth<br /><br>-Interaction of tidal volumes in the first 5 minutes after birth with time<br /><br>-Average rate of rise to maximum tidal volumes in the first 5 minutes after birth<br /> <br>-Interaction of rate of rise to maximum tidal volumes in the first 5 minutes after birth with time<br>-Percentage of recruitment breaths with tidal volumes above 8 ml/kg in the first 5 minutes after birth<br /><br>-Concentration of 8-iso-prostaglandin F2á(25), an oxidative stress metabolite associated with hyperoxia in blood. This blood sample will be taken together with the sample for measuring standard blood analyses, so that the infant will not be exposed to an extra venepuncture or capillary puncture. <br><br>
© Copyright 2025. All Rights Reserved by MedPath